GLP-1 Drugs Taking When Already Thin: The Surprising Truth Behind Off-Label Use

GLP-1 Drugs Taking When Already Thin: The Surprising Truth Behind Off-Label Use

The pharmaceutical revolution of GLP-1 drugs—originally designed for diabetes—has quietly reshaped how thin patients approach their health. While headlines scream about weight loss, the reality is far more nuanced: a growing number of individuals with normal BMI are turning to medications like semaglutide or tirzepatide not to lose pounds, but to rewire their metabolism, stabilize … Read more

What Happens When You Stop Taking GLP-1? The Science, Risks, and Real-World Impact

What Happens When You Stop Taking GLP-1? The Science, Risks, and Real-World Impact

The first sign is often subtle: a quiet, almost imperceptible shift in the body’s rhythm. For those who’ve relied on GLP-1 agonists like semaglutide or tirzepatide to tame hunger, stabilize blood sugar, or shed decades of stubborn weight, the decision to stop can feel like stepping off a cliff—except the drop isn’t always visible at … Read more